These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 4036762)
1. Tryptophan metabolism in patients with breast cancer. Poulter JM; Dickerson JW; White WF Acta Vitaminol Enzymol; 1985; 7(1-2):93-7. PubMed ID: 4036762 [TBL] [Abstract][Full Text] [Related]
2. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors]. Holtkamp W; von Heyden D; Rauschecker H; Nagel GA Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641 [TBL] [Abstract][Full Text] [Related]
3. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China. Lampe JW; Nishino Y; Ray RM; Wu C; Li W; Lin MG; Gao DL; Hu Y; Shannon J; Stalsberg H; Porter PL; Frankenfeld CL; Wähälä K; Thomas DB Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2579-86. PubMed ID: 18086761 [TBL] [Abstract][Full Text] [Related]
4. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Schrauzer GN; Molenaar T; Mead S; Kuehn K; Yamamoto H; Araki E Jpn J Cancer Res; 1985 May; 76(5):374-7. PubMed ID: 3924710 [TBL] [Abstract][Full Text] [Related]
5. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women. Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910 [TBL] [Abstract][Full Text] [Related]
6. Serum total and free prostate-specific antigen for breast cancer diagnosis in women. Black MH; Giai M; Ponzone R; Sismondi P; Yu H; Diamandis EP Clin Cancer Res; 2000 Feb; 6(2):467-73. PubMed ID: 10690525 [TBL] [Abstract][Full Text] [Related]
7. Plasma and erythrocyte total antioxidant status in patients with benign and malign breast disease. Afrasyap L; Güvenen G; Türkmen S Cancer Biochem Biophys; 1998 Jun; 16(1-2):129-38. PubMed ID: 9923972 [TBL] [Abstract][Full Text] [Related]
8. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease. England PC; Sellwood RA; Knyba RE; Irvine JD Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319 [No Abstract] [Full Text] [Related]
9. [Clinical aspects of the radioimmunoassay of carcinoembryonic antigen levels in breast cancer]. Agranat VZ; Baliura AV; Nikogosian GA; Smolina TA; Iass NIa Med Radiol (Mosk); 1983 Aug; 28(8):34-7. PubMed ID: 6888209 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer--the role of free radicals and antioxidants in pathogenesis of benign dysplasia and breast carcinoma. Szpringer E; Madej B; Kurylcio L; Czerny K; Lutnicki K; Górny D; Maciejewski R; Kurylcio A Ann Univ Mariae Curie Sklodowska Med; 2000; 55():11-7. PubMed ID: 11482059 [No Abstract] [Full Text] [Related]
11. Paradoxical effects associated with supranormal urinary testosterone excretion in premenopausal women with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy. Secreto G; Zumoff B Cancer Res; 1983 Jul; 43(7):3408-11. PubMed ID: 6850646 [TBL] [Abstract][Full Text] [Related]
12. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)]. Iturburu Belmonte IM; Basáñez Amuchastegui A; Jiménez Jiménez E; López de Tejada Cabeza I; Goicoechea García J; Méndez Martín J Rev Quir Esp; 1988; 15(1):17-21. PubMed ID: 3153353 [No Abstract] [Full Text] [Related]
13. The estriol quotient in fibrocystic disease, a high-risk group for breast cancer. Bagli NP; Shah PN; Mistry SS Indian J Cancer; 1980 Dec; 17(4):201-4. PubMed ID: 7228103 [No Abstract] [Full Text] [Related]
14. Significance of alterations in plasma lipid profile levels in breast cancer. Franky Dhaval Shah ; Shilin Nandubhai Shukla ; Pankaj Manubhai Shah ; Patel HR; Prabhudas Shankerbhai Patel Integr Cancer Ther; 2008 Mar; 7(1):33-41. PubMed ID: 18292593 [TBL] [Abstract][Full Text] [Related]
16. [Changes in serum alpha 1-antitrypsin in benign and malignant breast diseases]. Millán Núñez-Cortés J; Senra Varela A Med Clin (Barc); 1984 Mar; 82(8):347-8. PubMed ID: 6609289 [No Abstract] [Full Text] [Related]
17. Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls. Schultz DC; Bazel S; Wright LM; Tucker S; Lange MK; Tachovsky T; Longo S; Niedbala S; Alhadeff JA Cancer Res; 1994 Jan; 54(1):48-54. PubMed ID: 8261461 [TBL] [Abstract][Full Text] [Related]
18. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast]. Korolev VI; Skliar SIu; Ponomarev IN Vrach Delo; 1988 Jan; (1):59-61. PubMed ID: 3363942 [No Abstract] [Full Text] [Related]
19. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast. Thynne GS; Greening WP Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405 [No Abstract] [Full Text] [Related]
20. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Gönenç A; Erten D; Aslan S; Akinci M; Simşek B; Torun M Cell Biol Int; 2006 Apr; 30(4):376-80. PubMed ID: 16616293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]